skin effects Firming Facial with Retinol Complex SPF 30

Product NDC: 42877-001
11-digit product format: 428770001
Labeler code: 42877
Product ID: 42877-001_968feffc-85c5-457e-a110-27001c8be572
Type: HUMAN OTC DRUG
Nonproprietary name: AVOBENZONE, OCTINOXATE,OCTISALATE
Dosage form: CREAM
Route: TOPICAL
Labeler: Diversified Global Technologies DBA Diversified Distribution
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2011-09-28
Marketing end: 0000-00-00
Substance: AVOBENZONE; OCTINOXATE; OCTISALATE
Active strength: 3 g/100g; g/100g; g/100g
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	42877-001		I	Inactivated by FDA		2026-10-16
excluded package	package	42877-001	42877-001-01	I	Inactivated by FDA		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42877-001-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42877-001-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42877-001-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42877-001-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42877-001-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42877-001-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42877-001-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42877-001-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42877-001-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42877-001-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42877-001-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42877-001-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42877-001-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42877-001-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42877-001-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	42877-001-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	42877-001-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	42877-001-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	42877-001-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	42877-001-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	42877-001-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	42877-001-01	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42877-001-01	2020-01-31	C162847	48780-1	9d75b9d1-2463-f424-e053-dadaa90a57ce	skin effects Firming Facial Cream with Retinol Complex SPF 30

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42877-001-01	skin effects Firming Facial with Retinol Complex SPF 30	28.3 g in 1 BOTTLE	CREAM	28.3		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
.ALPHA.-TOCOPHEROL ACETATE, D-	INACTIVE INGREDIENT	A7E6112E4N	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
ALUMINUM STARCH OCTENYLSUCCINATE	INACTIVE INGREDIENT	I9PJ0O6294	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
C13-14 ISOPARAFFIN	INACTIVE INGREDIENT	E4F12ROE70	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
CETETH-20	INACTIVE INGREDIENT	I835H2IHHX	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
HEXYLENE GLYCOL	INACTIVE INGREDIENT	KEH0A3F75J	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
O-CYMEN-5-OL	INACTIVE INGREDIENT	H41B6Q1I9L	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
OCTYLDODECYL NEOPENTANOATE	INACTIVE INGREDIENT	X8725R883T	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
PEG-75 STEARATE	INACTIVE INGREDIENT	OT38R0N74H	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
PENTYLENE GLYCOL	INACTIVE INGREDIENT	50C1307PZG	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
POLYSORBATE 20	INACTIVE INGREDIENT	7T1F30V5YH	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
RETINOL	INACTIVE INGREDIENT	G2SH0XKK91	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
STEARETH-2	INACTIVE INGREDIENT	V56DFE46J5	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
TETRAHEXYLDECYL ASCORBATE	INACTIVE INGREDIENT	9LBV3F07AZ	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42877-001	SKIN EFFECTS FIRMING FACIAL WITH RETINOL COMPLEX SPF 30 (AVOBENZONE, OCTINOXATE,OCTISALATE) CREAM [DIVERSIFIED GLOBAL TECHNOLOGIES DBA DIVERSIFIED DISTRIBUTION]	2	Legacy NDC, 1 package rows	20111013_0b57744a-f5da-47f9-bdb2-8b5fe7920ace.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G63QQF2NOX	AVOBENZONE	70356-09-1	AVOBENZONE
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
4X49Y0596W	OCTISALATE	118-60-5	OCTISALATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
42877-001-01	42877000101	28.3 g in 1 BOTTLE	28.3 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
skin effects Firming Facial Cream with Retinol Complex SPF 30	Diversified Global Technologies DBA Diversified Distribution	2011-10-12	HUMAN OTC DRUG LABEL	2